Your browser doesn't support javascript.
loading
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.
Khaemba, Christabel; Barry, Abbie; Omondi, Wyckliff P; Bota, Kefa; Matendechero, Sultani; Wandera, Cecilia; Siyoi, Fred; Kirui, Elvis; Oluka, Margaret; Nambwa, Pamela; Gurumurthy, Parthasarathi; Njenga, Sammy M; Guantai, Anastacia; Aklillu, Eleni.
Afiliación
  • Khaemba C; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.
  • Barry A; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya.
  • Omondi WP; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.
  • Bota K; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.
  • Matendechero S; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.
  • Wandera C; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.
  • Siyoi F; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya.
  • Kirui E; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya.
  • Oluka M; Ministry of Health -National Public Health Laboratory, Kenyatta National Hospital Grounds, 20750-00202 Nairobi, Kenya.
  • Nambwa P; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya.
  • Gurumurthy P; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya.
  • Njenga SM; Pharmacovigilance and Clinical Trials, Botswana Medicines Regulatory Authority, Gaborone 505155, Botswana.
  • Guantai A; Kenya Medical Research Institute (KEMRI), 54840-00200 Nairobi, Kenya.
  • Aklillu E; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya.
Pharmaceuticals (Basel) ; 14(3)2021 Mar 15.
Article en En | MEDLINE | ID: mdl-33804133
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Suecia